Timeline of NIHR's response to COVID-19
COVID-19 updates
- 23 March 2023 - How NIHR Applied Research Collaborations rose to the challenge of COVID-19News:
- 02 March 2023 - New research to understand immune responses against COVID-19 vaccinationNews:
- 29 November 2022 - New study will help rapidly find flu treatments this winterNews:
- 28 November 2022 - Study finds blood thinning drug does not improve recovery from severe COVID-19News:
- 12 October 2022 - NIHR Clinical Research Network High Level Objectives Outturn Report 2021/22Document: NIHR Clinical Research Networks High Level Objectives Outturn report 2021/22
- 19 August 2022 - First real-world study suggests when people with COVID-19 are most infectiousNews:
- 15 August 2022 - NIHR welcomes MHRA approval of Moderna Omicron COVID-19 boosterNews:
- 05 August 2022 - COVID-19 restrictions not directly linked to distress in EnglandNews:
- 25 July 2022 - Hair and libido loss join fatigue and brain fog among list of long COVID symptomsNews:
- 19 July 2022 - COVID-19 vaccine study calls on pregnant women to help build upon booster dose guidanceNews:
- 29 June 2022 - Sex, age and existing health problems increase risk of long COVIDNews:
- 28 June 2022 - Interrupting treatment of vulnerable people on immune-suppressing medicines doubles their antibody response to COVID-19 booster vaccinationNews:
- 09 June 2022 - COVID-19 vaccine study supports flexible intervals in mixed Pfizer and Oxford/AstraZeneca schedulesNews:
- 30 May 2022 - COVID-19 vaccination associated with reduced risk of long COVIDNews:
- 26 May 2022 - Com-COV vaccine study to analyse 3rd dose booster options for 12 to 15 year-oldsNews:
- 17 May 2022 - How the NIHR mobilised and adapted the UK research landscape to deliver COVID-19 studiesBlog:
- 10 May 2022 - Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK studyNews:
- 27 April 2022 - Researchers create new tool to assess symptoms of long COVIDNews:
- 21 April 2022 - COVID-19 vaccine boosters give well-maintained immunity three months on, finds NIHR-supported COV-BOOST trialNews:
- 14 April 2022 - NIHR welcomes UK approval of Valneva COVID-19 vaccineNews:
- 12 April 2022 - Antiviral treatment Paxlovid investigated through PANORAMIC studyNews:
- 25 March 2022 - The perfect storm: How COVID-19 public health messages may not serve ethnic minority communitiesBlog:
- 07 March 2022 - Genetic study gives further details into severe COVID-19News:
- 03 March 2022 - RECOVERY Trial shows baricitinib reduces deaths in COVID-19 hospitalised patientsNews:
- 24 February 2022 - Innovative model identifies high-risk people for priority COVID-19 vaccinationCase Study: NIHR-funded researchers have developed a model called QCovid® that predicts the risk of people becoming seriously ill or dying from COVID-19. The model has been used to inform UK health policy, and its use by NHS Digital helped prioritise 820,000 people for vaccination.
- 16 February 2022 - UK volunteers to receive Moderna Omicron COVID-19 booster vaccine in clinical studyNews:
- 08 February 2022 - New definitions for long COVID developed with patients and carersNews:
- 03 February 2022 - NIHR welcomes UK approval of the Novavax COVID-19 vaccineNews:
- 25 January 2022 - COVID-19 antivirals study UK’s fastest ever recruiting trial of its kindNews:
- 18 January 2022 - COVID-19 vaccine lower booster dose study launches across UKNews:
- 04 January 2022 - Early data for multivariant COVID-19 vaccine booster shows promiseNews:
- 22 December 2021 - Demographic and household factors drive difference in COVID-19 infection risk for healthcare workers from ethnic minority groupsNews:
- 17 December 2021 - World’s first plant-based COVID-19 vaccine trialled in the UK shares positive resultsNews:
- 14 December 2021 - UK clinical research ecosystem continues to build on learnings from COVID-19 researchNews:
- 08 December 2021 - Ground-breaking COVID-19 antiviral treatment trial opens to recruitmentNews:
- 03 December 2021 - NIHR supported study publishes COVID-19 booster dataNews:
- 25 November 2021 - Pregnant women called upon for COVID-19 vaccine study to shape future guidanceNews:
- 21 October 2021 - Vaccination greatly reduces risk of dying from COVID-19 Delta variantNews:
- 02 October 2021 - Vaccination effective against severe COVID-19 but some groups still at riskNews:
- 01 October 2021 - Vaccinating against COVID-19 and influenza at the same time is safe, shows NIHR studyNews:
- 20 September 2021 - Tool identifies vaccinated groups at highest risk of severe COVID-19News:
- 17 September 2021 - Com-COV alternating vaccine dose study expands to 12-to-16-year-oldsNews:
- 16 September 2021 - Data from NIHR-supported studies inform UK COVID-19 Booster ProgrammeNews:
- 15 September 2021 - Institutions eligible as hosts for NIHR Global Research ProfessorshipsDocument: Institutions eligible to host applicants for NIHR Global Research Professorships
- 02 September 2021 - First findings from world’s largest study on long COVID in children and young peopleNews:
- 03 August 2021 - COVID-19 vaccine dose interval study for pregnant women launchesNews:
- 18 July 2021 - £19.6 million awarded to new research studies to help diagnose and treat long COVIDNews:
- 16 July 2021 - People with five or more symptoms more likely to develop long COVIDNews:
- 14 July 2021 - Improving the uptake of research findings in global healthBlog:
- 28 June 2021 - Mixed Oxford and Pfizer vaccine schedules shows robust immune response against COVID-19News:
- 24 June 2021 - Up to one in three people who have had COVID-19 report long COVID symptomsNews:
- 20 May 2021 - World-first COVID-19 Vaccine Booster Study Launches in UKNews:
- 17 May 2021 - First UK COVID-19 vaccine study for pregnant women launchesNews:
- 12 April 2021 - Asthma drug shortens recovery time in non-hospitalised patients with COVID-19News:
- 08 April 2021 - Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trialNews:
- 01 April 2021 - Policy Research Programme COVID-19 researchDocument: A list of COVID-19 research projects funded through the Policy Research Programme's rapid COVID-19 funding process, or supported from existing funding to Policy Research Units.
- 25 March 2021 - NIHR launches second £20 million Long COVID funding callNews:
- 25 March 2021 - New NIHR-funded drug trial launched to prevent deaths after COVID patients leave hospitalNews:
- 25 March 2021 - Long COVID call 2021 - Theme 2: Diagnostics and Other Guidance for applicationsDocument: This document provides guidance for applicants submitting research proposals on Diagnostics, plus other topics to help and support individuals with Long COVID, for NIHR's 2021 funding call on Long COVID in non-hospitalised individuals.
- 22 February 2021 - Vaccination reduces Covid-19 hospital admissions, NIHR study suggestsNews:
- 18 February 2021 - £18.5 million awarded to new research projects to understand and treat long COVIDNews:
- 11 February 2021 - RECOVERY trial shows tocilizumab reduces deaths in patients hospitalised with COVID-19News:
- 04 February 2021 - World's first COVID-19 vaccine alternating dose study launches in UKNews:
- 02 February 2021 - RECOVERY trial investigates baricitinib as potential COVID-19 treatmentNews:
- 02 February 2021 - Arthritis drugs effective in improving survival in sickest COVID-19 patientsNews:
- 29 January 2021 - Novavax COVID-19 vaccine 89.3% effectiveNews:
- 26 January 2021 - New trial to test drugs for preventing Covid-19 in care homesNews:
- 25 January 2021 - PRINCIPLE trial finds no benefit from antibiotics, azithromycin and doxycycline for COVID-19 patientsNews:
- 21 January 2021 - Why we need to test COVID-19 testsBlog:
- 18 January 2021 - Studies find no evidence of convalescent plasma benefit for hospitalised COVID-19 patientsNews:
- 09 January 2021 - Online tool identifies COVID-19 patients at highest risk of deteriorationNews:
- 07 January 2021 - Arthritis drugs effective in improving survival in sickest COVID-19 patientsNews:
- 30 December 2020 - NIHR and UKRI welcome UK approval of Oxford-led Covid-19 vaccineNews:
- 14 December 2020 - RECOVERY trial shows no clinical benefit from azithromycin for hospitalised patientsNews:
- 01 December 2020 - The long journey to understanding the mental health impact of COVID-19Blog:
- 24 November 2020 - Serving the under-served – how NIHR’s INCLUDE initiative will make trials better reflect all members of societyBlog:
- 23 November 2020 - Oxford COVID-19 vaccine 70% effectiveNews:
- 19 November 2020 - Arthritis drug effective in treating sickest COVID-19 patientsNews:
- 17 November 2020 - Reflections on the first wave: a research midwife’s experienceBlog:
- 13 October 2020 - People from Black, Asian and Minority Ethnic backgrounds and the elderly encouraged to participate in vital COVID-19 vaccine studiesNews:
- 12 October 2020 - Understanding the impact of the pandemic on people with mental ill healthBlog:
- 09 October 2020 - Black and Asian patients have increased risk of severe COVID-19 at different stages of the diseaseNews:
- 18 September 2020 - REMAP-CAP tests treatments for COVID-19Case Study: The NIHR is supporting REMAP-CAP; a nationally-prioritised study which aims to provide answers about the best treatment options for COVID-19 patients who develop pneumonia.
- 18 September 2020 - Testing treatments for COVID-19 at homeCase Study: The PRINCIPLE trial is the first study to test potential treatments for COVID-19 through GP surgeries and in the community.
- 18 September 2020 - Seeking effective alternatives to mechanical ventilation for COVID-19 patients - the RECOVERY-Respiratory Support TrialCase Study: A landmark NIHR-funded and supported trial provides vital evidence to help resolve internationally conflicting guidance about respiratory support for severely ill COVID-19 patients. The results will reduce the need for mechanical ventilation and decrease the burden on critical care wards.
- 18 September 2020 - Harnessing genetics to treat serious illness from COVID-19 - GenOMICCCase Study: Since 2016 the GenOMICC study has been researching what genetic factors affect whether people become severely ill from an infection. With the help of the NIHR, the study has rapidly ramped up to investigate coronavirus infection, studying genes from hundreds of very unwell patients to help understand what treatments might help tackle COVID-19.
- 18 September 2020 - Harnessing a pioneering cell therapy treatment for COVID-19 patients with acute respiratory failure - the REALIST trialCase Study: The REALIST trial is offering an innovative cell therapy treatment for patients with acute respiratory failure caused by COVID-19.
- 18 September 2020 - The UK's flagship COVID-19 treatment trial - the RECOVERY trialCase Study: The NIHR-supported RECOVERY trial is leading the way in identifying treatments for this new infectious disease.
- 14 September 2020 - RECOVERY trial to evaluate new monoclonal antibody combination treatmentNews:
- 14 September 2020 - New study to trial inhaled COVID-19 vaccinesNews:
- 02 September 2020 - New studies reinforce evidence that corticosteroids improve survival rates among critically ill COVID-19 patientsNews:
- 31 July 2020 - #Covid19ResearchVoices: Our experience as Covid-19 Medical Student VolunteersBlog:
- 29 July 2020 - Investigating the risks of COVID-19 for ethnic minority healthcare workers - UK-REACHCase Study: Healthcare workers from black, Asian and minority ethnic (BAME) backgrounds are putting their own health at risk to care for patients with COVID-19. But new research funded by the NIHR and UKRI, part of a multimillion package of new projects on COVID-19 and ethnicity, aims to understand that risk and provide evidence to inform the response to the pandemic.
- 20 July 2020 - First trial results show UK coronavirus vaccine produces a strong immune responseNews:
- 16 July 2020 - #Covid19ResearchVoices: Removing the cloak of invisibilityBlog:
- 09 July 2020 - #Covid19ResearchVoices: Going back to the frontlineBlog:
- 05 July 2020 - Major study into long-term health effects of COVID-19 launched in the UKNews:
- 03 July 2020 - #Covid19ResearchVoices: Research on the frontlineBlog:
- 01 July 2020 - Ensuring ethnic diversity in COVID-19 researchBlog:
- 30 June 2020 - #Covid19ResearchVoices: Answering the call to support our health servicesBlog:
- 26 June 2020 - #Covid19ResearchVoices: The multi-fold benefits of integrating research in standard careBlog:
- 23 June 2020 - New risk prediction model could help improve guidance for people shielding from COVID-19News:
- 23 June 2020 - "Just Do It" - Phil’s COVID-19 Research StoryCase Study: Phil was hospitalised with COVID-19 in early April 2020. Struggling to breathe, he was grateful to take part in the RECOVERY-RS trial. One year on, Phil has made a slow recovery and is now back at work, he told us his story.
- 19 June 2020 - #Covid19ResearchVoices: Why clinical research is more important now than everBlog:
- 18 June 2020 - Delivering commercial Urgent Public Health Research: SynairgenCase Study: Following recruitment success in hospitals, Synairgen’s clinical trial of a new inhaled treatment for coronavirus infection turns its attention to COVID-19 patients in the community.
- 16 June 2020 - First drug to reduce mortality in hospitalised patients with respiratory complications of COVID-19 foundNews:
- 15 June 2020 - Trial seeks to resolve conflicting guidance about respiratory support for severely ill COVID-19 patientsNews:
- 12 June 2020 - Large scale lockdowns in Europe saved millions of livesNews:
- 05 June 2020 - #Covid19ResearchVoices: Research has never been so importantBlog:
- 01 June 2020 - #Covid19ResearchVoices: Diary of an ICU nurseBlog:
- 29 May 2020 - Patients to benefit from access to new treatment being trialled in the NHSNews:
- 15 May 2020 - #Covid19ResearchVoices: Research in primary care: It’s a matter of PRINCIPLEBlog:
- 12 May 2020 - Graeme's RECOVERY - Taking part in a COVID-19 trialCase Study: A man who beat coronavirus and was among the first patients to enrol on the NIHR-supported RECOVERY trial, has spoken of how he wanted to “step up” to help with research into treatments for the disease.
- 12 May 2020 - Pregnant women are not at greater risk of severe COVID-19 than other womenNews:
- 01 May 2020 - #Covid19ResearchVoices: Leading the research delivery team at NHS Nightingale North WestBlog:
- 24 April 2020 - #Covid19ResearchVoices: Diving into the unknownBlog:
- 17 March 2020 - COVID-19 message for all NIHR Academy MembersDocument: The latest information in relation to current and future NIHR awards, including any guidance published for NIHR Academy Members in relation to the impact of COVID-19.
- NIHR COVID-19 page